Global Oligonucleotides Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 102
Published Date: 04 Jun 2021
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oligonucleotides size is estimated to be USD 1657.9 million in 2026 from USD 1146.3 million in 2020, with a change XX% between 2020 and 2021. The global Oligonucleotides market size is expected to grow at a CAGR of 9.7% for the next five years.
Market segmentation
Oligonucleotides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA Oligos
RNA Oligos
Market segment by Application, can be divided into
Pharmaceutical
Research
Diagnostic
Market segment by players, this report covers
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oligonucleotides, with revenue, gross margin and global market share of Oligonucleotides from 2019 to 2021.
Chapter 3, the Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oligonucleotides market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oligonucleotides research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oligonucleotides
1.2 Classification of Oligonucleotides by Type
1.2.1 Overview: Global Oligonucleotides Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oligonucleotides Revenue Market Share by Type in 2020
1.2.3 DNA Oligos
1.2.4 RNA Oligos
1.3 Global Oligonucleotides Market by Application
1.3.1 Overview: Global Oligonucleotides Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Oligonucleotides Market Size & Forecast
1.5 Global Oligonucleotides Market Size and Forecast by Region
1.5.1 Global Oligonucleotides Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oligonucleotides Market Size by Region, (2016-2021)
1.5.3 North America Oligonucleotides Market Size and Prospect (2016-2026)
1.5.4 Europe Oligonucleotides Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oligonucleotides Market Size and Prospect (2016-2026)
1.5.6 South America Oligonucleotides Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oligonucleotides Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oligonucleotides Market Drivers
1.6.2 Oligonucleotides Market Restraints
1.6.3 Oligonucleotides Trends Analysis
2.1 Integrated DNA Technologies
2.1.1 Integrated DNA Technologies Details
2.1.2 Integrated DNA Technologies Major Business
2.1.3 Integrated DNA Technologies Oligonucleotides Product and Solutions
2.1.4 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Integrated DNA Technologies Recent Developments and Future Plans
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business
2.2.3 Agilent Oligonucleotides Product and Solutions
2.2.4 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Recent Developments and Future Plans
2.3 Sigma-aldrich
2.3.1 Sigma-aldrich Details
2.3.2 Sigma-aldrich Major Business
2.3.3 Sigma-aldrich Oligonucleotides Product and Solutions
2.3.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sigma-aldrich Recent Developments and Future Plans
2.4 Eurofins Genomics
2.4.1 Eurofins Genomics Details
2.4.2 Eurofins Genomics Major Business
2.4.3 Eurofins Genomics Oligonucleotides Product and Solutions
2.4.4 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Eurofins Genomics Recent Developments and Future Plans
2.5 L.G.C Biosearch Technologies
2.5.1 L.G.C Biosearch Technologies Details
2.5.2 L.G.C Biosearch Technologies Major Business
2.5.3 L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
2.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
2.6 Eurogentec S.A
2.6.1 Eurogentec S.A Details
2.6.2 Eurogentec S.A Major Business
2.6.3 Eurogentec S.A Oligonucleotides Product and Solutions
2.6.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eurogentec S.A Recent Developments and Future Plans
2.7 Nitto Denko Avecia Inc
2.7.1 Nitto Denko Avecia Inc Details
2.7.2 Nitto Denko Avecia Inc Major Business
2.7.3 Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
2.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Nitto Denko Avecia Inc Recent Developments and Future Plans
2.8 GenScript
2.8.1 GenScript Details
2.8.2 GenScript Major Business
2.8.3 GenScript Oligonucleotides Product and Solutions
2.8.4 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GenScript Recent Developments and Future Plans
2.9 BBI Life Sciences
2.9.1 BBI Life Sciences Details
2.9.2 BBI Life Sciences Major Business
2.9.3 BBI Life Sciences Oligonucleotides Product and Solutions
2.9.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BBI Life Sciences Recent Developments and Future Plans
2.10 GeneDesign
2.10.1 GeneDesign Details
2.10.2 GeneDesign Major Business
2.10.3 GeneDesign Oligonucleotides Product and Solutions
2.10.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 GeneDesign Recent Developments and Future Plans
2.11 TriLink BioTechnologies
2.11.1 TriLink BioTechnologies Details
2.11.2 TriLink BioTechnologies Major Business
2.11.3 TriLink BioTechnologies Oligonucleotides Product and Solutions
2.11.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 TriLink BioTechnologies Recent Developments and Future Plans
2.12 SGS DNA
2.12.1 SGS DNA Details
2.12.2 SGS DNA Major Business
2.12.3 SGS DNA Oligonucleotides Product and Solutions
2.12.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 SGS DNA Recent Developments and Future Plans
2.13 LC Sciences
2.13.1 LC Sciences Details
2.13.2 LC Sciences Major Business
2.13.3 LC Sciences Oligonucleotides Product and Solutions
2.13.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 LC Sciences Recent Developments and Future Plans
2.14 Twist Bioscience
2.14.1 Twist Bioscience Details
2.14.2 Twist Bioscience Major Business
2.14.3 Twist Bioscience Oligonucleotides Product and Solutions
2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Twist Bioscience Recent Developments and Future Plans
2.15 Creative Biogene
2.15.1 Creative Biogene Details
2.15.2 Creative Biogene Major Business
2.15.3 Creative Biogene Oligonucleotides Product and Solutions
2.15.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Creative Biogene Recent Developments and Future Plans
2.16 General Biosystems
2.16.1 General Biosystems Details
2.16.2 General Biosystems Major Business
2.16.3 General Biosystems Oligonucleotides Product and Solutions
2.16.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 General Biosystems Recent Developments and Future Plans
3.1 Global Oligonucleotides Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oligonucleotides Players Market Share
3.2.2 Top 10 Oligonucleotides Players Market Share
3.2.3 Market Competition Trend
3.3 Oligonucleotides Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Oligonucleotides Revenue and Market Share by Type (2016-2021)
4.2 Global Oligonucleotides Market Forecast by Type (2021-2026)
5.1 Global Oligonucleotides Revenue Market Share by Application (2016-2021)
5.2 Oligonucleotides Market Forecast by Application (2021-2026)
6.1 North America Oligonucleotides Revenue by Type (2016-2026)
6.2 North America Oligonucleotides Revenue by Application (2016-2026)
6.3 North America Oligonucleotides Market Size by Country
6.3.1 North America Oligonucleotides Revenue by Country (2016-2026)
6.3.2 United States Oligonucleotides Market Size and Forecast (2016-2026)
6.3.3 Canada Oligonucleotides Market Size and Forecast (2016-2026)
6.3.4 Mexico Oligonucleotides Market Size and Forecast (2016-2026)
7.1 Europe Oligonucleotides Revenue by Type (2016-2026)
7.2 Europe Oligonucleotides Revenue by Application (2016-2026)
7.3 Europe Oligonucleotides Market Size by Country
7.3.1 Europe Oligonucleotides Revenue by Country (2016-2026)
7.3.2 Germany Oligonucleotides Market Size and Forecast (2016-2026)
7.3.3 France Oligonucleotides Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oligonucleotides Market Size and Forecast (2016-2026)
7.3.5 Russia Oligonucleotides Market Size and Forecast (2016-2026)
7.3.6 Italy Oligonucleotides Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Oligonucleotides Revenue by Type (2016-2026)
8.2 Asia-Pacific Oligonucleotides Revenue by Application (2016-2026)
8.3 Asia-Pacific Oligonucleotides Market Size by Region
8.3.1 Asia-Pacific Oligonucleotides Revenue by Region (2016-2026)
8.3.2 China Oligonucleotides Market Size and Forecast (2016-2026)
8.3.3 Japan Oligonucleotides Market Size and Forecast (2016-2026)
8.3.4 South Korea Oligonucleotides Market Size and Forecast (2016-2026)
8.3.5 India Oligonucleotides Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oligonucleotides Market Size and Forecast (2016-2026)
8.3.7 Australia Oligonucleotides Market Size and Forecast (2016-2026)
9.1 South America Oligonucleotides Revenue by Type (2016-2026)
9.2 South America Oligonucleotides Revenue by Application (2016-2026)
9.3 South America Oligonucleotides Market Size by Country
9.3.1 South America Oligonucleotides Revenue by Country (2016-2026)
9.3.2 Brazil Oligonucleotides Market Size and Forecast (2016-2026)
9.3.3 Argentina Oligonucleotides Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Oligonucleotides Revenue by Type (2016-2026)
10.2 Middle East & Africa Oligonucleotides Revenue by Application (2016-2026)
10.3 Middle East & Africa Oligonucleotides Market Size by Country
10.3.1 Middle East & Africa Oligonucleotides Revenue by Country (2016-2026)
10.3.2 Turkey Oligonucleotides Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oligonucleotides Market Size and Forecast (2016-2026)
10.3.4 UAE Oligonucleotides Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oligonucleotides Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oligonucleotides Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oligonucleotides Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oligonucleotides Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oligonucleotides Revenue Market Share by Region (2021-2026)
Table 6. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 7. Integrated DNA Technologies Major Business
Table 8. Integrated DNA Technologies Oligonucleotides Product and Solutions
Table 9. Integrated DNA Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Major Business
Table 12. Agilent Oligonucleotides Product and Solutions
Table 13. Agilent Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sigma-aldrich Corporate Information, Head Office, and Major Competitors
Table 15. Sigma-aldrich Major Business
Table 16. Sigma-aldrich Oligonucleotides Product and Solutions
Table 17. Sigma-aldrich Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Eurofins Genomics Corporate Information, Head Office, and Major Competitors
Table 19. Eurofins Genomics Major Business
Table 20. Eurofins Genomics Oligonucleotides Product and Solutions
Table 21. Eurofins Genomics Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. L.G.C Biosearch Technologies Corporate Information, Head Office, and Major Competitors
Table 23. L.G.C Biosearch Technologies Major Business
Table 24. L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
Table 25. L.G.C Biosearch Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eurogentec S.A Corporate Information, Head Office, and Major Competitors
Table 27. Eurogentec S.A Major Business
Table 28. Eurogentec S.A Oligonucleotides Product and Solutions
Table 29. Eurogentec S.A Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Nitto Denko Avecia Inc Corporate Information, Head Office, and Major Competitors
Table 31. Nitto Denko Avecia Inc Major Business
Table 32. Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
Table 33. Nitto Denko Avecia Inc Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GenScript Corporate Information, Head Office, and Major Competitors
Table 35. GenScript Major Business
Table 36. GenScript Oligonucleotides Product and Solutions
Table 37. GenScript Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BBI Life Sciences Corporate Information, Head Office, and Major Competitors
Table 39. BBI Life Sciences Major Business
Table 40. BBI Life Sciences Oligonucleotides Product and Solutions
Table 41. BBI Life Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. GeneDesign Corporate Information, Head Office, and Major Competitors
Table 43. GeneDesign Major Business
Table 44. GeneDesign Oligonucleotides Product and Solutions
Table 45. GeneDesign Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. TriLink BioTechnologies Corporate Information, Head Office, and Major Competitors
Table 47. TriLink BioTechnologies Major Business
Table 48. TriLink BioTechnologies Oligonucleotides Product and Solutions
Table 49. TriLink BioTechnologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. SGS DNA Corporate Information, Head Office, and Major Competitors
Table 51. SGS DNA Major Business
Table 52. SGS DNA Oligonucleotides Product and Solutions
Table 53. SGS DNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. LC Sciences Corporate Information, Head Office, and Major Competitors
Table 55. LC Sciences Major Business
Table 56. LC Sciences Oligonucleotides Product and Solutions
Table 57. LC Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Twist Bioscience Corporate Information, Head Office, and Major Competitors
Table 59. Twist Bioscience Major Business
Table 60. Twist Bioscience Oligonucleotides Product and Solutions
Table 61. Twist Bioscience Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Creative Biogene Corporate Information, Head Office, and Major Competitors
Table 63. Creative Biogene Major Business
Table 64. Creative Biogene Oligonucleotides Product and Solutions
Table 65. Creative Biogene Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. General Biosystems Corporate Information, Head Office, and Major Competitors
Table 67. General Biosystems Major Business
Table 68. General Biosystems Oligonucleotides Product and Solutions
Table 69. General Biosystems Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Oligonucleotides Revenue (USD Million) by Players (2019-2021)
Table 71. Global Oligonucleotides Revenue Share by Players (2019-2021)
Table 72. Breakdown of Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Oligonucleotides Players Head Office, Products and Services Provided
Table 74. Oligonucleotides Mergers & Acquisitions in the Past Five Years
Table 75. Oligonucleotides New Entrants and Expansion Plans
Table 76. Global Oligonucleotides Revenue (USD Million) by Type (2016-2021)
Table 77. Global Oligonucleotides Revenue Share by Type (2016-2021)
Table 78. Global Oligonucleotides Revenue Forecast by Type (2021-2026)
Table 79. Global Oligonucleotides Revenue by Application (2016-2021)
Table 80. Global Oligonucleotides Revenue Forecast by Application (2021-2026)
Table 81. North America Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Oligonucleotides Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Oligonucleotides Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oligonucleotides Picture
Figure 2. Global Oligonucleotides Revenue Market Share by Type in 2020
Figure 3. DNA Oligos
Figure 4. RNA Oligos
Figure 5. Oligonucleotides Revenue Market Share by Application in 2020
Figure 6. Pharmaceutical Picture
Figure 7. Research Picture
Figure 8. Diagnostic Picture
Figure 9. Global Oligonucleotides Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Oligonucleotides Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Oligonucleotides Revenue Market Share by Region (2016-2026)
Figure 12. Global Oligonucleotides Revenue Market Share by Region in 2020
Figure 13. North America Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Oligonucleotides Market Drivers
Figure 19. Oligonucleotides Market Restraints
Figure 20. Oligonucleotides Market Trends
Figure 21. Integrated DNA Technologies Recent Developments and Future Plans
Figure 22. Agilent Recent Developments and Future Plans
Figure 23. Sigma-aldrich Recent Developments and Future Plans
Figure 24. Eurofins Genomics Recent Developments and Future Plans
Figure 25. L.G.C Biosearch Technologies Recent Developments and Future Plans
Figure 26. Eurogentec S.A Recent Developments and Future Plans
Figure 27. Nitto Denko Avecia Inc Recent Developments and Future Plans
Figure 28. GenScript Recent Developments and Future Plans
Figure 29. BBI Life Sciences Recent Developments and Future Plans
Figure 30. GeneDesign Recent Developments and Future Plans
Figure 31. TriLink BioTechnologies Recent Developments and Future Plans
Figure 32. SGS DNA Recent Developments and Future Plans
Figure 33. LC Sciences Recent Developments and Future Plans
Figure 34. Twist Bioscience Recent Developments and Future Plans
Figure 35. Creative Biogene Recent Developments and Future Plans
Figure 36. General Biosystems Recent Developments and Future Plans
Figure 37. Global Oligonucleotides Revenue Share by Players in 2020
Figure 38. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Oligonucleotides Revenue Market Share in 2020
Figure 40. Global Top 10 Players Oligonucleotides Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Oligonucleotides Revenue Share by Type in 2020
Figure 43. Global Oligonucleotides Market Share Forecast by Type (2021-2026)
Figure 44. Global Oligonucleotides Revenue Share by Application in 2020
Figure 45. Global Oligonucleotides Market Share Forecast by Application (2021-2026)
Figure 46. North America Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 47. North America Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 48. North America Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 49. United States Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 53. Europe Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 54. Europe Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 55. Germany Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Oligonucleotides Revenue Market Share by Region (2016-2026)
Figure 63. China Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 70. South America Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 71. South America Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Integrated DNA Technologies Agilent Sigma-aldrich Eurofins Genomics L.G.C Biosearch Technologies Eurogentec S.A Nitto Denko Avecia Inc GenScript BBI Life Sciences GeneDesign TriLink BioTechnologies SGS DNA LC Sciences Twist Bioscience Creative Biogene General Biosystems
Related Reports
04 Jan 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
